IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $437,000 | +41.9% | 85,660 | -32.7% | 0.02% | +66.7% |
Q3 2019 | $308,000 | -35.0% | 127,305 | +154.6% | 0.02% | +7.1% |
Q3 2018 | $474,000 | -90.7% | 50,006 | -90.5% | 0.01% | -91.1% |
Q2 2018 | $5,124,000 | -3.3% | 526,660 | +4.5% | 0.16% | -7.1% |
Q1 2018 | $5,300,000 | +69.1% | 503,765 | +3.0% | 0.17% | +76.0% |
Q4 2017 | $3,135,000 | -16.5% | 489,035 | -0.3% | 0.10% | -19.3% |
Q3 2017 | $3,753,000 | +141.8% | 490,635 | +124.7% | 0.12% | +183.3% |
Q2 2017 | $1,552,000 | – | 218,320 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |